← back to search

Turgay Dalkara

Bilkent University · TR
Area of research
Cellular and Molecular Neuroscience · Neurology
Research interest
Research interests include Neuroscience and Neuropharmacology Research, Barrier Structure and Function Studies, Acute Ischemic Stroke Management, and Migraine and Headache Studies.
h-index
54
citations
15,259
works
227
NIH funding
primary concept
email

Recent publications

Academia Europaea’s guidelines for the visualization of clinical outcomes
Nature Medicine 2025cited by 1position: middledoi
NUDT6, the Antisense Protein of FGF2 Gene, Plays a Depressogenic Role by Promoting Inflammation and Suppressing Neurogenesis without Altering FGF2 Signaling
bioRxiv (Cold Spring Harbor Laboratory) 2022cited by 0position: middledoi
Stress modulates cortical excitability via α-2 adrenergic and glucocorticoid receptors: As assessed by spreading depression
Experimental Neurology 2018cited by 27position: lastdoi
Murine Sialidase Neu3 facilitates GM2 degradation and bypass in mouse model of Tay-Sachs disease
Experimental Neurology 2017cited by 81position: middledoi
Cerebral microvascular pericytes and neurogliovascular signaling in health and disease
Brain Research 2015cited by 134position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

· 2 papers (2017–2018) · 2 papers (2018–2022) · 1 papers (2017–2017)Johanna von Gerichten · University of Surrey1 papers (2017–2017)Kazunori Yamaguchi · Japan Display (Japan)1 papers (2017–2017) · 1 papers (2017–2017) · 1 papers (2017–2017) · 1 papers (2022–2022) · 1 papers (2022–2022)Carsten Hopf · Heidelberg Engineering (Germany)1 papers (2017–2017)Christian Marsching · Technische Hochschule Mannheim1 papers (2017–2017) · 1 papers (2017–2017)Roger Sandhoff · German Cancer Research Center1 papers (2017–2017)Luis Alarcón-Martínez · Barrow Neurological Institute1 papers (2015–2015) · 1 papers (2017–2017) · 1 papers (2018–2018) · 1 papers (2017–2017) · 1 papers (2017–2017)Yavuz Ayhan · Johns Hopkins Medicine1 papers (2022–2022) · 1 papers (2022–2022)